Evidence map›Paper›PMID 38814543›Full record

ArticleJournal of assisted reproduction and genetics2024

Rescue in vitro maturation using ovarian support cells of human oocytes from conventional stimulation cycles yields oocytes with improved nuclear maturation and transcriptomic resemblance to in vivo matured oocytes.

Bruna Paulsen, Sabrina Piechota, Ferran Barrachina, Alexa Giovannini, Simone Kats, Kathryn S Potts, Graham Rockwell, Maria Marchante, Samantha L Estevez, Alexander D Noblett and 19 more

Abstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Bruna Paulsen *Gameto Inc., 430 E. 29th St Fl 14, New York, NY, 10016, USA.
Sabrina Piechota *Gameto Inc., 430 E. 29th St Fl 14, New York, NY, 10016, USA.
Ferran Barrachina *Gameto Inc., 430 E. 29th St Fl 14, New York, NY, 10016, USA.
Alexa GiovanniniGameto Inc., 430 E. 29th St Fl 14, New York, NY, 10016, USA.
Simone KatsGameto Inc., 430 E. 29th St Fl 14, New York, NY, 10016, USA.
Kathryn S PottsGameto Inc., 430 E. 29th St Fl 14, New York, NY, 10016, USA.
Graham RockwellGameto Inc., 430 E. 29th St Fl 14, New York, NY, 10016, USA.
Maria MarchanteGameto Inc., 430 E. 29th St Fl 14, New York, NY, 10016, USA.
Samantha L EstevezObstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Alexander D NoblettGameto Inc., 430 E. 29th St Fl 14, New York, NY, 10016, USA.
Alexandra B FigueroaGameto Inc., 430 E. 29th St Fl 14, New York, NY, 10016, USA.
Caroline AschenbergerGameto Inc., 430 E. 29th St Fl 14, New York, NY, 10016, USA.
Dawn A KelkExtend Fertility, New York, NY, USA.
Marcy FortiExtend Fertility, New York, NY, USA.
Shelby MarcinyshynExtend Fertility, New York, NY, USA.
Klaus WiemerKEW Technology, Seattle, WA, USA.
Marta SanchezRuber Juan Bravo University Hospital, Eugin Group, Madrid, Spain.
Pedro BelchinRuber Juan Bravo University Hospital, Eugin Group, Madrid, Spain.
Joseph A LeeReproductive Medicine Associates of New York, New York, NY, USA.
Erkan BuyukObstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Rick E SlifkinReproductive Medicine Associates of New York, New York, NY, USA.
Merrick Pierson SmelaWyss Institute, Harvard Medical School, Boston, MA, USA.
Patrick R J FortunaWyss Institute, Harvard Medical School, Boston, MA, USA.
Pranam ChatterjeeDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.
David H McCullohGameto Inc., 430 E. 29th St Fl 14, New York, NY, 10016, USA.
Alan B CoppermanObstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Daniel Ordonez-PerezRuber Juan Bravo University Hospital, Eugin Group, Madrid, Spain.
Joshua U KleinExtend Fertility, New York, NY, USA.
Christian C KrammeGameto Inc., 430 E. 29th St Fl 14, New York, NY, 10016, USA. christian@gametogen.com.ORCID http://orcid.org/0000-0002-7518-8111

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDetermine if the gene expression profiles of ovarian support cells (OSCs) and cumulus-free oocytes are bidirectionally influenced by co-culture during in vitro maturation (IVM).

methodsFertility patients aged 25 to 45 years old undergoing conventional ovarian stimulation donated denuded immature oocytes for research. Oocytes were randomly allocated to either OSC-IVM culture (intervention) or Media-IVM culture (control) for 24-28 h. The OSC-IVM culture condition was composed of 100,000 OSCs in suspension culture with human chorionic gonadotropin (hCG), recombinant follicle stimulating hormone (rFSH), androstenedione, and doxycycline supplementation. The Media-IVM control lacked OSCs and contained the same supplementation. A limited set of in vivo matured MII oocytes were donated for comparative evaluation. Endpoints consisted of MII formation rate, morphological and spindle quality assessment, and gene expression analysis compared to in vitro and in vivo controls.

resultsOSC-IVM resulted in a statistically significant improvement in MII formation rate compared to the Media-IVM control, with no apparent effect on morphology or spindle assembly. OSC-IVM MII oocytes displayed a closer transcriptomic maturity signature to IVF-MII controls than Media-IVM control MII oocytes. The gene expression profile of OSCs was modulated in the presence of oocytes, displaying culture- and time-dependent differential gene expression during IVM.

conclusionThe OSC-IVM platform is a novel tool for rescue maturation of human oocytes, yielding oocytes with improved nuclear maturation and a closer transcriptomic resemblance to in vivo matured oocytes, indicating a potential enhancement in oocyte cytoplasmic maturation. These improvements on oocyte quality after OSC-IVM are possibly occurring through bidirectional crosstalk of cumulus-free oocytes and ovarian support cells.

Indexed as

In Vitro Oocyte Maturation TechniquesOocytesOvulation InductionTranscriptomeAdultChorionic GonadotropinCoculture TechniquesCumulus CellsFemaleFertilization in VitroFollicle Stimulating HormoneHumansMiddle AgedOvaryChorionic GonadotropinFollicle Stimulating HormoneGranulosa cellsIn vitro maturationOocyte transcriptomicsOvarian support cellsStem cells

Identifiers

PMID38814543
PMCPMC11339229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.